NEW YORK (GenomeWeb News) — Correlogic Systems has signed a research and development agreement with a Japanese mass-spec maker to enhance clinical mass spectrometry, Correlogic said today.

 

Correlogic and Tokyo-based JEOL, which also makes nuclear magnetic resonance instruments and electron optical equipment, have been involved in an “informal” research collaboration for more than a year, Correlogic said. The firm said they have “made great strides in the continuing validation of various mass spectrometer-based assays.”